Iron overload associated symptoms and laboratory changes in the Swiss Haemochromatosis Cohort - when a clinician should become attentive.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
13 Jul 2020
Historique:
entrez: 31 7 2020
pubmed: 31 7 2020
medline: 19 8 2021
Statut: epublish

Résumé

Hereditary haemochromatosis is a genetic disease characterised by progressive accumulation of iron in organs leading to many unspecific complaints, but even today diagnosis may be delayed. We aimed to identify symptoms associated with iron overload and parameters typical in patients with hereditary haemochromatosis which might help to facilitate detection and diagnosis in daily clinical routine. We analysed the prospective Swiss Haemochromatosis Cohort (SHC), including 163 patients for whom serum ferritin levels at diagnosis were available. The cohort was stratified according to the degree of iron overload. Substantial iron overload was defined as serum ferritin concentrations ≥1000 µg/ml. Patients with substantial iron overload had significantly higher liver enzymes (p <0.001) and more often arthropathy of the metacarpophalangeal joints (p <0.001) and upper ankle joint (p = 0.003). Elevated liver enzymes, especially elevated alanine aminotransferase (ALT) levels, were associated with a 10.1-fold (95% confidence interval [CI] 4.8–21.2) increased the risk for serum ferritin levels ≥1000 µg/ml. Furthermore, metacarpophalangeal joint arthropathy emerged as an important predictor for iron overload with a 3.6-fold increased risk (95% CI 1.8–7.1; p <0.001). Only elevated ALT levels and metacarpophalangeal joint arthropathy remained significantly associated with elevated iron levels after adjustment for possible confounders in patients diagnosed with hereditary haemochromatosis. Elevated ALT levels and metacarpophalangeal arthropathy remained independently associated with elevated ferritin levels in patients with haemochromatosis and should prompt clinicians to consider iron overload in patients with hereditary haemochromatosis.   &nbsp.

Identifiants

pubmed: 32729933
doi: 10.4414/smw.2020.20294
pii: Swiss Med Wkly. 2020;150:w20294
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

w20294

Auteurs

Sebastian Kölmel (S)

Department of Internal Medicine, Linth Hospital, Uznach, Switzerland.

Albina Nowak (A)

Department of Endocrinology and Clinical Nutrition, University Hospital Zurich, Switzerland / Department of Internal Medicine, Psychiatric University Hospital Zurich, Switzerland.

Pierre-Alexandre Krayenbuehl (PA)

Department of Internal Medicine, Linth Hospital, Uznach, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH